Skip to main content
. 2008 Sep 22;26(32):5233–5239. doi: 10.1200/JCO.2008.16.5449

Fig 1.

Fig 1.

(A) Schedule of treatments administered for three lymphodepleting cell transfer regimens. (B) Kaplan-Meier plot showing the duration of survival of patients treated on each lymphodepleting cell transfer protocol. Vertical tick marks indicate patients who are still alive and on study. Cy, cyclophosphamide; Flu, fludarabine; TBI, total-body irradiation; CD34+, hematopoietic stem cells; TIL, tumor-infiltrating lymphocytes; IL-, interleukin.